Core needle or resected tumor biopsies at baseline from primary ICC are referred to as P-ICC, whereas tumor biopsies from ICC samples treated with ICBs (PD-1 or PD-L1/CTLA-4) are denoted as T-ICC. The gene discussed is CTLA4; the disease is intrahepatic cholangiocarcinoma.